BMN 270-301: A Phase 3 Open-Label, Single-Arm Study To Evaluate The Efficacy and Safety of BMN 270, an Adeno-Associated Virus Vector-Mediated Gene Transfer of Human Factor VIII in Hemophilia A Patients with Residual FVIII Level

  • Thompson, Alexis A (PD/PI)

Project: Research project

Project Details

Effective start/end date3/12/198/31/50


  • BioMarin Pharmaceutical Inc.